🇺🇸 FDA

Company profile · Sponsor

CanSino

CanSino Biologics

C8498EF · NMPA pharma CN
Pipeline
3
Drugs
0
Patents
0

Quick answer

CanSino (C8498EF) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C8498EF
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (3)

Search pipeline →

  1. batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)

    CanSino

    Meningococcal Meningitis

    phase 3 mab active

    1 trial

  2. Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio) low adjuvant dose

    CanSino

    Poliomyelitis

    phase 2 mab active

    1 trial

  3. Tuberculosis (TB) vaccine (Ad5-105K)

    CanSino

    Tuberculosis

    phase 1 mab active

    1 trial

Frequently asked questions

What is CanSino?

CanSino (C8498EF) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does CanSino sponsor?

We track 3 ClinicalTrials.gov-linked programs for CanSino, including batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4) and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does CanSino company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.